Imunon, Inc. Proceeds from Sale of Short-term Investments
Imunon, Inc. (IMNN) reported Proceeds from Sale of Short-term Investments of $3.50 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfShortTermInvestments · last filed 2022-11-14
- Imunon, Inc. proceeds from sale of short-term investments for the quarter ending 2022-09-30 was $0.00.
| Period end | Proceeds from Sale of Short-term Investments 3 month | Proceeds from Sale of Short-term Investments 6 month | Proceeds from Sale of Short-term Investments 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.50M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.50M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |